COVID-19限制对儿童过敏敏感性的影响:一个三阶段比较研究
1Department of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Scientific reports
|November 13, 2025
概括
由于COVID-19的限制影响了儿童对过敏原的敏感性. 虽然限制降低了过敏的患病率,但解除这些限制和随后的COVID-19急剧增加了过敏性疾病的活动.
科学领域:
- 儿科过敏和免疫学
- 过敏疾病的流行病学
- 公共卫生干预措施的影响
背景情况:
- 随着COVID-19大流行和相关限制,日常生活发生了重大变化,这可能会影响儿童过敏疾病的流行率和严重程度.
- 了解这些变化对于在不断变化的公共卫生环境中管理儿科过敏症至关重要.
研究的目的:
- 调查COVID-19限制和随后的放松管制对儿童过敏原敏感性和过敏性疾病活性的影响.
- 分析过敏原特异性免疫球蛋白E (sIgE) 阳性,水平和多敏化模式的变化.
主要方法:
- 在放松管制之前,放松管制后和2021年相应期间接受过敏原测试的儿科患者的回顾性分析.
- 对过敏原特异性IgE (sIgE) 阳性率,IgE水平和多敏感性的评估.
- 对过敏患病率和疾病活动变化的统计分析.
主要成果:
- 在放松管制后,与放松管制前和2021年期间相比,观察到儿科过敏诊所访问的减少.
- 过敏原阳性率和sIgE水平在放松管制后低于在放松管制前,但高于2021年.
- 牛奶和牛肉敏感性之间的相关性在放松管制后与放松管制前相比减弱,但与2021年相比增强.
结论:
- COVID-19的限制与儿童过敏性疾病活动的减少有关.
- 与2021年期间相比,取消限制和随后的COVID-19激增与过敏性疾病活动的增加有关.
- 这些发现突显了环境因素,公共卫生措施和儿科过敏症之间的动态关系.
更多相关视频
相关概念视频
Allergic Reactions
31.9K
Overview
31.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
375
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K


